GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in April 2013. https://www.reportscorner.com/reports/20900/Partnerships,-Licensing,-Investments-and-M&A-Deals-and-Trends-for-April-2013-in-Pharmaceuticals/

1. RC
Reports Corner
Partnerships, Licensing, Investments and M&A Deals
and Trends for April 2013 in Pharmaceuticals

2. DescriptionDescription
Reports Cornerwww.reportscorner.com
GlobalData's "Partnerships, Licensing, Investments and M&A
Deals and Trends for April 2013 in Pharmaceuticals" report is an
essential source of data and trend analysis on partnerships,
licensing, mergers and acquisitions (M&As) and financings in the
pharmaceuticals industry. The report provides detailed
information on partnership and licensing transactions, M&As,
equity/debt offerings, private equity, and venture financing
registered in the pharmaceuticals industry in April 2013.

3. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Partnerships, Licensing, Investments and M&A Deals and Trends
for April 2013 in Pharmaceuticals
Summary
GlobalData's "Partnerships, Licensing, Investments and M&A
Deals and Trends for April 2013 in Pharmaceuticals" report is an
essential source of data and trend analysis on partnerships,
licensing, mergers and acquisitions (M&As) and financings in the
pharmaceuticals industry. The report provides detailed
information on partnership and licensing transactions, M&As,
equity/debt offerings, private equity, and venture financing
registered in the pharmaceuticals industry in April 2013. The
report portrays detailed comparative data on the number of deals
and their value in the last six months, subdivided by deal types,
various therapy areas, and geographies.

4. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Additionally, the report provides information on the top financial
advisory firms in the pharmaceuticals industry.
Data presented in this report is derived from GlobalData’s
proprietary in-house deals database and primary and secondary
research.
Note: Certain sections in the report may be removed or altered
based on the availability and relevance of data for the indicated
disease.
Scope
- Data on the number of clinical trials conducted in North America,
South and Central America, Europe, Middle-East and Africa and

5. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Asia-pacific and top five national contributions in each, along with
the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial
status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and
terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a
condensed manner
- Abridged view of the performance of the trials in terms of their
status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities /
Institutes / Hospitals or Companies

6. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, April 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, April 2013 9
2.2.1 Thermo Fisher Scientific to Acquire Life Technologies for US$13.6 Billion 9
2.2.2 Sanofi Completes Public Offering of Notes Due 2018 for US$1.5 Billion 10
2.2.3 Bayer to Acquire Conceptus, Contraceptive Devices Maker for US$1.1 Billion 10
2.2.4 Roper Industries Completes Acquisition of Managed Health Care Associates for US$1 Billion 10
2.2.5 Covidien Prices Private Placement of Notes for US$900 Million 10
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, April 2013 11
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, April 2013 12
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 13

7. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
3.1 Pharmaceuticals & Healthcare, Global, M&A, April 2013 13
3.1.1 Top M&A Deals in April 2013 14
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, November 2012–April 2013 15
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, April 2013 16
3.2.1 Top Equity Offering Deals in April 2013 17
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, November 2012– April
2013 18
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, April 2013 19
3.3.1 Top PE/VC Deals in April 2013 20
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, April 2013 21
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, April 2013 22
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, November 2012– April 2013 24
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, November 2012–April 2013 25
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, April 2013 26
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, April 2013 26

8. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, November 2012– April 2013
27
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal
Values (US$ m), April 2013 28
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, April 2013 29
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone
Payments and Deal Values (US$ m), November 2012– April 2013 30
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, November 2012–
April 2013 31
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), November
2012– April 2013 32
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments
and Deal Values (US$ m), November 2012– April 2013 33
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, April 2013 34
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, April 2013 34
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments
and Deal Values (US$ m), April 2013 35
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, April 2013 36

9. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, April
2013 36
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, April
2013 36
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values
(US$ m), November 2012– April 2013 37
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments
and Milestone Payments (US$ m), November 2012 – April 2013 38
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$
m), November 2012 – April 2013 39
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and
Milestone Payments (US$ m), November 2012– April 2013 41
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 42
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, April 2013 42
6.1.1 Oncology – Deals of the Month 43
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, April 2013 45
6.2.1 Central Nervous System – Deals of the Month 46
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, April 2013 47

10. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
6.3.1 Infectious Diseases – Deals of the Month 48
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, April 2013 49
6.4.1 Cardiovascular – Deal of the Month 50
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, April 2013 51
6.5.1 Metabolic Disorders – Deal of the Month 52
6.6 Pharmaceuticals & Healthcare, Global, Immunology Deals, April 2013 53
6.6.1 Immunology – Deal of the Month 54
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, April 2013 55
6.7.1 Respiratory – Deal of the Month 56
7 Deal Summary by Geography 57
7.1 Pharmaceuticals & Healthcare, North America Deals, April 2013 57
7.1.1 North America – Deals of the Month 58
7.2 Pharmaceuticals & Healthcare, Europe, Deals, April 2013 59
7.2.1 Europe – Deals of the Month 60
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, April 2013 61

11. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
7.3.1 Asia-Pacific – Deals of the Month 62
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, April 2013 63
7.4.1 Rest of the World – Deals of the Month 64
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 65
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, November 2012 – April 2013 65
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, November 2012 –
April 2013 66
9 Further Information 67
9.1 Methodology 67
9.2 About GlobalData 68
9.3 Contact Us 68
9.4 Disclosure information 68
9.5 Disclaimer 68

12. For more informationFor more information
Reports Cornerwww.reportscorner.com
For more information please visit our website
https://www.reportscorner.com/reports/20900/Partnerships,-Licensing,-Investments-
and-M&A-Deals-and-Trends-for-April-2013-in-Pharmaceuticals/

13. Reports Corner
Thank YouThank You
www.reportscorner.com
RC
Contact us: contact@reportscorner.com